Media contacts


 

Meghana Sharafudeen
+41 79 711 5554
msharafudeen@gavi.org
 

Meghana Sharafudeen

Laura Shevlin
+ 41 79 529 92 87
lshevlin@gavi.org
 

Laura Shevlin

Cirũ Kariũki
+41 79 913 94 41
ckariuki@gavi.org
 

Cirũ Kariũki

Collins Weru Mwai
+250787836638
cmwai@gavi.org

Collins Weru Mwai

Eunice Kilonzo-Muraya
+41 76 424 85 03
ekilonzo@gavi.org

Eunice Kilonzo-Muraya

Latest news releases

View all releases

New deals announced to catalyse vaccine manufacturing in Africa

The African Vaccine Manufacturing Accelerator (AVMA), launched in June 2024 to catalyse investment in Africa’s vaccine manufacturing ecosystem, has already begun building confidence for groundbreaking partnerships, with two new collaborations…

9 million vaccine doses administered to children living in humanitarian settings in the Horn of Africa

Gavi and IRC’s REACH Consortium administers 9 million vaccine doses, protecting against diseases such as measles and diphtheria

Government of Canada and Gavi deliver 200,000 doses of donated mpox vaccine to DRC

A shipment of 200,000 mpox vaccine doses donated by Canada and facilitated by Gavi, the Vaccine Alliance has arrived in the DRC.

Media resources | assets

If you would you like to receive updates from the Gavi media team, or request access to our digital library of high-resolution images and B-roll, please email media@gavi.org.

Facts and figures

GAVI/2017/Guido Dingemans/Mozambique

Gavi progress reports

Credit: Gavi/2013/Evelyn Hockstein

Types of support

Gavi/2017/Juliette Bastin/Burkina Faso

Communication toolkits

Gavi/2024/Jjumba Martin

Country hub

Country hub

Snap analyses

Gavi/2022/Benedikt v.Loebell

Gavi leadership

 

José Manuel Barroso
Board Chair

José Manuel Barroso

Dr Sania Nishtar
CEO

Dr Sania Nishtar

Opinions

View all opinions

Gavi at 25: Our ambition is greater than ever

Over its 25 years, Gavi, the Vaccine Alliance, has played a pivotal role in improving global health by vaccinating over one billion children in low-income countries.

The Vaccine Alliance in 2023

Prof José Manuel Barroso, Chair of the Gavi Board, and Dr Sania Nishtar, CEO of Gavi since 18 March 2024, reflect on the driving forces of progress in 2023 and plans for 2024.

How the lessons of COVID-19 ensured a rapid vaccine response to the mpox outbreak

Lessons learned from the COVID-19 pandemic enabled rapid access to vaccine financing during the early stages of the mpox emergency.

Last updated: 6 Feb 2025

Subscribe to our newsletter